KDR and non-Hodgkin lymphoma: This study performed on CD133+/CD34+/VEGFR2+ EPCs in PB and lymph nodes of patients with NHL highlighted an increased number of circulating EPCs in NHL younger patients with more aggressive disease and reduced levels of EPCs in patients with incomplete response to treatments.